Perioperative Cognitive Protection-Dexmedetomidine and Cognitive Reserve

围术期认知保护——右美托咪定与认知储备

基本信息

批准号：
7322906
负责人：
JEFFREY H SILVERSTEIN
金额：
$ 56.41万
依托单位：
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
起止时间：
2007-09-30 至 2012-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7322906
关键词：
Absence of pain sensation Accounting Activities of Daily Living Adrenergic Agonists Agonist Analgesics Anesthesia and Analgesia Anesthesia procedures Anesthetics Appearance Area Argipressin Arousal Attention Baby Booms Behavior Brain Cardiac Surgery procedures Cerebral Ischemia Circadian Rhythms Clinical Cognitive Community Hospitals Confusion Critical Illness Data Delirium Deterioration Development Dexmedetomidine Disease Disorientation Distress Drug usage Elderly Endorphins Enrollment Epinephrine Etiology Evaluation Failure Family Follow-Up Studies Functional disorder General Anesthesia Generations Geriatric Psychiatry Goals Health Care Costs Health Expenditures Healthcare Hospitals Hour Hydrocortisone Impaired cognition Incidence Infusion procedures Length of Stay Lesion Light Measurable Measures Mediating Medical Surveillance Midazolam Minor Surgical Procedures Morbidity - disease rate Neuraxis Neurologic Neuropsychology Neurosecretory Systems Norepinephrine Operative Surgical Procedures Pain Participant Patients Performance Perioperative Pharmaceutical Preparations Pharmacology Physicians Placebos Population Postoperative Period Prevalence Principal Investigator Propofol Public Health Randomized Randomized Clinical Trials Randomized Controlled Clinical Trials Randomized Controlled Trials Rate Recovery Research Personnel Risk Risk Factors Role Saliva Sampling Score Sedation procedure Sensory Severities Sleep Standards of Weights and Measures Stress Syndrome Techniques Testing Thinking Translating Uncertainty United States Waxes Work base biological adaptation to stress clinically significant cognitive function cognitive reserve concept cost day disability experience follow-up improved indexing innovation interest medical complication mild neurocognitive impairment mortality older patient prevent programs response sedative

项目摘要

DESCRIPTION (provided by applicant): Elderly patients who undergo anesthesia and non-cardiac surgery are subject to deterioration of brain function including the development of postoperative delirium (PD) and postoperative cognitive dysfunction (POCD). These disorders cause disability, distress for both patients and their families, are associated with other medical complications and account for significant additional health care costs. We currently use relatively primative approaches to preventing and treating PD and POCD. The proposed project expands on previous work exploring PD and POCD to propose a randomized controlled trial of perioperative dexmedetomidine to prevent PD and, potentially, POCD. Seven hundred and six patients will be enrolled at seven centers representing both academic and community hospitals. Participants will undergo preoperative cognitive testing and provide saliva samples for cortisol. Patients will be randomized to either dexmedetomidine or placebo which will be started prior to surgery and continued for 24 hours postoperatively. Follow up studies will include surveillance for delirium while in the hospital and cognitive testing at 3 and 6 months following surgery. Part of the neuropsychologic evaluation will include an assessment for mild cognitive impairment(MCI). Dexmedetomidine is a drug used for sedation in critically ill patients that provides some pain relief and controls the bodies response to stress. The sedation produced by dexmedetomidine appears more similar to natural sleep than any other drug used for anesthesia and postoperative sedation. Data indicating that dexmedetomidine can prevent delirium following cardiac surgery and the developing understanding of the causes of PD and POCD suggest that dexmedetomidine will be particularly effective. The proposed project includes important efforts to further define POCD and understand the pathophysiology of these problems. The evaluation of patients for MCI represents a particularly important and challenging innovation in the study of PD and POCD. PUBLIC HEALTH: Almost eight million elderly patients had surgery in 2004. Perhaps 10% of those patients suffer from problems that can be thought of as postoperative brain failure. These problems are extremely expensive in terms of health care dollars and cause significant disability - representing the next challenge for physicians as they confront the increasing surgical burden of the baby boom generation.

描述（由申请人提供）：接受麻醉和非心脏手术的老年患者脑功能恶化，包括术后del妄（PD）和术后认知功能障碍（POCD）的发展。这些疾病会导致残疾，患者及其家人的困扰与其他医疗并发症有关，并造成了额外的医疗保健费用。我们目前使用相对原则的方法来预防和治疗PD和POCD。拟议的项目扩展了探索PD和POCD的先前工作，以提出围手术期右美托咪定的随机对照试验，以防止PD和POCD。 76名患者将在代表学术和社区医院的七个中心招收。参与者将接受术前认知测试，并为皮质醇提供唾液样本。患者将被随机分配给右美托咪定或安慰剂，该甲米丁或安慰剂将在手术前开始，并在术后持续24小时。后续研究将包括在医院期间对ir妄的监视以及手术后3和6个月的认知测试。神经心理学评估的一部分将包括对轻度认知障碍的评估（MCI）。右美托汀是一种用于镇静患者的药物，可减轻疼痛，并控制身体对压力的反应。与用于麻醉和术后镇静的任何其他药物相比，右美托咪定产生的镇静似乎更像自然睡眠。数据表明右美托咪定可以防止心脏手术后del妄，并且对PD和POCD的原因的发展表明右美托咪定将特别有效。拟议的项目包括进一步定义POCD并了解这些问题的病理生理学的重要努力。在PD和POCD研究中，对MCI的患者评估是一项特别重要且具有挑战性的创新。公共卫生：2004年，近800万名老年患者进行了手术。大概有10％的患者患有可以认为是术后脑衰竭的问题。这些问题在医疗保健收入方面非常昂贵，并且会导致严重的残疾 - 这代表了医生面对婴儿繁荣产生的手术负担的下一个挑战。